Allarity Therapeutics
(NASDAQ) ALLR
Allarity Therapeutics Financials at a Glance
Market Cap
$23.89M
Revenue (TTM)
$345.00K
Net Income (TTM)
$11.25M
EPS (TTM)
$-0.79
P/E Ratio
-1.90
Dividend
$0.00
Beta (Volatility)
1.05 (Average)
Dividend
$0.00
Beta (Volatility)
1.05 (Average)
Price
$1.37
Volume
258,138.761
Open
$1.50
Price
$1.37
Volume
258,138.761
Open
$1.50
Previous Close
$1.35
Daily Range
$1.34 - $1.50
52-Week Range
$0.77 - $2.35
Dividend
$0.00
Beta (Volatility)
1.05 (Average)
Price
$1.37
Volume
258,138.761
Open
$1.50
Previous Close
$1.35
Daily Range
$1.34 - $1.50
52-Week Range
$0.77 - $2.35
ALLR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Allarity Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Thomas H. Jensen
Website
www.allarity.comHeadquarters
Boston, MA 02139, US
ALLR Financials
Key Financial Metrics (TTM)
Gross Margin
93%
Operating Margin
-36%
Net Income Margin
-33%
Return on Equity
-104%
Return on Capital
-2%
Return on Assets
-32%
Earnings Yield
-52.63%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$23.89M
Shares Outstanding
15.82M
Volume
258.14K
Avg. Volume
177.61K
Financials (TTM)
Gross Profit
$320.00K
Operating Income
$12.61M
EBITDA
$11.05M
Operating Cash Flow
$14.82M
Capital Expenditure
$8.00K
Free Cash Flow
$14.83M
Cash & ST Invst.
$14.69M
Total Debt
$1.40M
Allarity Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$25.00K
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$23.89M
N/A
Market Cap/Employee
$3.98M
N/A
Employees
6
N/A
Net Income
$2.75M
-0.7%
EBITDA
$2.69M
-0.9%
Quarterly Fundamentals
Net Cash
$19.81M
-16.9%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-32.21%
N/A
Return on Invested Capital
-1.77%
N/A
Free Cash Flow
$4.56M
-69.7%
Operating Cash Flow
$4.49M
-67.3%